Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy
- Conditions
- Essential HypertensionType 2 DiabetesNephropathy
- Interventions
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Sichuan Academy of Medical Sciences
- Target Recruit Count
- 297
- Registration Number
- NCT06501651
- Locations
- 🇨🇳
Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital, Chengdu, Sichuan, China
Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients
- Conditions
- Peritoneal Dialysis ComplicationRenal Function AggravatedSodium-glucose Co-transporter-2 Inhibitors
- Interventions
- First Posted Date
- 2024-05-03
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Sichuan Academy of Medical Sciences
- Target Recruit Count
- 70
- Registration Number
- NCT06398977
- Locations
- 🇨🇳
Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospita, Chengdu, Sichuan, China
Exercise Improves Gastrointestinal Function in Peritoneal Dialysis Patients
- Conditions
- Gastrointestinal FunctionPeritoneal DialysisQuality of LifeChronic Kidney DiseasesExercise
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Sichuan Academy of Medical Sciences
- Target Recruit Count
- 132
- Registration Number
- NCT06368713
- Locations
- 🇨🇳
Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital,School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China
Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke
- Conditions
- Acute Ischemic StrokeAlteplaseEndovascular TreatmentBasilar Artery OcclusionThrombosis
- Interventions
- Procedure: Endovascular treatmentDrug: Intravenous thrombolysis (Alteplase)
- First Posted Date
- 2022-11-30
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Sichuan Academy of Medical Sciences
- Target Recruit Count
- 340
- Registration Number
- NCT05631847
- Locations
- 🇨🇳
Banan Hospital Affiliated to Chongqing Medical University, Chongqing, Chongqing, China
🇨🇳Chongqing Sanbo Chang'an Hospital, Chongqing, Chongqing, China
🇨🇳Chongqing University Affiliated S Central Hospital, Chongqing, Chongqing, China
Metabolomics Dynamics Study for Severe Patient
- Conditions
- Age:18-70 YearsAcute Physiology And Chronic Health Evaluation(APACHE)II>10Acute Severe Disease
- First Posted Date
- 2014-06-17
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- Sichuan Academy of Medical Sciences
- Target Recruit Count
- 600
- Registration Number
- NCT02164786
- Locations
- 🇨🇳
Sichuan Academy of Medical Sciences, Chengdu, Sichuan, China
- Prev
- 1
- 2
- Next